Eflornithine Is Safer than Melarsoprol for the Treatment of Second-Stage Trypanosoma brucei gambiense Human African Trypanosomiasis
Open Access
- 1 September 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (5) , 748-751
- https://doi.org/10.1086/432576
Abstract
Patients with second-stage human African trypanosomiasis treated with eflornithine (n = 251) in 2003 in Kiri, southern Sudan, had an adjusted relativKeywords
This publication has 5 references indexed in Scilit:
- Efficacy of 10-day melarsoprol schedule 2 years after treatment for late-stage gambiense sleeping sicknessThe Lancet, 2004
- Treatment of human African trypanosomiasis—present situation and needs for research and developmentThe Lancet Infectious Diseases, 2002
- The phenomenon of treatment failures in Human African TrypanosomiasisTropical Medicine & International Health, 2001
- Eflornithine concentrations in serum and cerebrospinal fluid of 63 patients treated for Trypanosoma brucei gambiense sleeping sicknessTransactions of the Royal Society of Tropical Medicine and Hygiene, 1993
- Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sicknessPublished by Elsevier ,1992